These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35236774)

  • 1. A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection.
    Hassler L; Wysocki J; Gelarden I; Sharma I; Tomatsidou A; Ye M; Gula H; Nicoleascu V; Randall G; Pshenychnyi S; Khurram N; Kanwar Y; Missiakas D; Henkin J; Yeldandi A; Batlle D
    J Am Soc Nephrol; 2022 Jul; 33(7):1293-1307. PubMed ID: 35236774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infection.
    Hassler L; Wysocki J; Gelarden I; Tomatsidou A; Gula H; Nicoleascu V; Randall G; Henkin J; Yeldandi A; Batlle D
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta Variant.
    Cianfarini C; Hassler L; Wysocki J; Hassan A; Nicolaescu V; Elli D; Gula H; Ibrahim AM; Randall G; Henkin J; Batlle D
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection.
    Hassler L; Wysocki J; Ahrendsen JT; Ye M; Gelarden I; Nicolaescu V; Tomatsidou A; Gula H; Cianfarini C; Khurram N; Kanwar Y; Singer BD; Randall G; Missiakas D; Henkin J; Batlle D
    bioRxiv; 2022 Dec; ():. PubMed ID: 36523403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection.
    Hassler L; Wysocki J; Ahrendsen JT; Ye M; Gelarden I; Nicolaescu V; Tomatsidou A; Gula H; Cianfarini C; Forster P; Khurram N; Singer BD; Randall G; Missiakas D; Henkin J; Batlle D
    Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37041017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection.
    Lu M; Yao W; Li Y; Ma D; Zhang Z; Wang H; Tang X; Wang Y; Li C; Cheng D; Lin H; Yin Y; Zhao J; Zhong G
    Microbiol Spectr; 2023 Aug; 11(4):e0110023. PubMed ID: 37395664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs.
    Singh V; Beer A; Kraus A; Mang F; Zhang X; Xue J; Hagemann N; Hermann DM; Gunzer M
    Brain Behav Immun; 2021 May; 94():458-462. PubMed ID: 33621620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
    Menon R; Otto EA; Sealfon R; Nair V; Wong AK; Theesfeld CL; Chen X; Wang Y; Boppana AS; Luo J; Yang Y; Kasson PM; Schaub JA; Berthier CC; Eddy S; Lienczewski CC; Godfrey B; Dagenais SL; Sohaney R; Hartman J; Fermin D; Subramanian L; Looker HC; Harder JL; Mariani LH; Hodgin JB; Sexton JZ; Wobus CE; Naik AS; Nelson RG; Troyanskaya OG; Kretzler M
    Kidney Int; 2020 Dec; 98(6):1502-1518. PubMed ID: 33038424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model.
    Vergara A; Jacobs-Cachá C; Molina-Van den Bosch M; Domínguez-Báez P; Benito B; García-Carro C; Serón D; Soler MJ
    Mol Cell Endocrinol; 2021 Jun; 529():111263. PubMed ID: 33811970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
    Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
    Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids.
    Wysocki J; Ye M; Hassler L; Gupta AK; Wang Y; Nicoleascu V; Randall G; Wertheim JA; Batlle D
    J Am Soc Nephrol; 2021 Apr; 32(4):795-803. PubMed ID: 33526471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
    Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.